Penumbra, Inc.

Headquartered in Alameda, California, Penumbra is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures, and markets new products, and has a broad portfolio addressing challenging medical conditions in markets with significant unmet needs. Penumbra provides support to healthcare providers, hospitals, and clinics in over 100 countries.

Institutional videos

Listen to Dr. Charles Matouk discuss the evolution of stroke treatment, how the COMPLETE study impacted Yale’s first ADAPT stroke practice, and why the RED is his catheter of choice.

Acute Ischemic Stroke
(Story 1)

The opinions and clinical experiences presented here are for informational purposes only. Results may not be predictive for all patients. Individual results may vary depending on a variety of specific patient attributes. Any treatment decision should be made in consultation with a healthcare professional based on a full discussion of risks and benefits. The views and opinions expressed here are those of the interviewee and do not necessarily reflect the views of Penumbra, Inc. or its affiliates. The physician featured is a consultant to Penumbra, Inc.

Organization

Collaborators

Sponsors

Organization

Collaborators

Sponsors

Our partners and sponsors

Achieving our vision of a life without stroke is a task we cannot do alone. We are committed to building our global, regional and national partnerships to expand and deliver improvements in prevention, treatment and support to reduce the burden of stroke.

We use cookies for the proper functioning of this website, as well as cookies to personalize content and advertisements, provide social media features and to obtain statistical and analytical information about the website. If you want to find out more about cookies and whether you can block them or if you want information about how we use data, please visit our Privacy Policy.